Prime Medicine, Inc. Common Stock (PRME)
Healthcare
Biotechnology
2.80 $
-3.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Prime Medicine, Inc. Common Stock (PRME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -163 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -1.3 | -5.5 | -34 | -132 | -165 | -123 | -163 | |
| 0.0 | 0.0 | 0.6 | 2.2 | 4.7 | 6.1 | 5.4 | |
| – | 0.4 | 1.7 | 6.5 | 14 | 26 | 29 | |
| 2.1 | -2.3 | 100 | 5.5 | – | – | – | |
| 0.5 | 0.2 | 31 | -35 | 2.6 | 31 | -5.3 | |
| 0.6 | 0.6 | 4.2 | 16 | 8.7 | 7.3 | 4.5 | |
| -1.1 | -1.1 | -74 | -47 | 19 | 68 | -109 | |
| – | – | – | 181 | – | – | – | |
| 10.0 | 35 | 269 | 181 | 0.7 | 196 | 152 | |
| 8.6 | 28 | 162 | 2.6 | -146 | 141 | -120 | |
| -1.3 | -6.2 | -38 | -148 | -174 | -130 | -167 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.